Active Biotech - Extra Shareholders' Meeting 19 October 2000.Business Wire STOCKHOLM, Sweden--(BUSINESS WIRE)--Oct. 19, 2000 At Active Biotech's extra shareholders' meeting today, it was decided that the number of members of the board should be increased, from eight to nine and to elect the following new directors: Mats Arnhog (born 1951). Mats Arnhog has a Master of Science in Business and Economics from Stockholm School of Economics The Stockholm School of Economics or Handelshögskolan i Stockholm is a business school and private university in Stockholm, Sweden. It was founded in 1909 to improve business education in Sweden. Controlled by a private trust, it also receives government support. , and is the current owner of the company MGA (1) (Monochrome Graphics Adapter) A display adapter that employs Hercules Graphics, combining graphics and text on a monochrome monitor. (2) (Matrox Graphics Accelerator) A trade name used by Matrox Graphics Inc. Holding. Mats Arnhog is, through MGA Holding, one of the major shareholders in Active Biotech with 6,1% of share capital and 28,9% of votes. In addition to his board appointments in different subsidiaries of MGA Holding, Mats Arnhog is also a Member of the Board in K-World. Maria Borelius (born 1960). Maria Borelius has a Bachelor of Science Noun 1. Bachelor of Science - a bachelor's degree in science BS, SB bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies in Biology with a Masters degree in Science journalism. She has experience from Sveriges Television, Sveriges Radio, TV4 and TV3, from programmes such as NOVA, Vetenskapens Varld and Vetandets Varld. Maria Borelius is part-owner and Senior Vice President of Learning Development, K-World, an Internet based knowledge- and educational company. Maria Borelius is a Member of the Board in Naturvetenskapliga Forskningradet. Peter Sjostrand (born 1946). Peter Sjostrand has a Master of Science in Business and Economics from Stockholm School of Economics and is a Medical Doctor, with 20 years experience from association with Astra's Board and Management, latest as Vice President (1988-93). Peter Sjostrand is mainly active abroad, as Member of the Board in Pharma Vision AG, Switzerland and Tularik Inc., USA. In Sweden he is Chairman of the Board in Meda AB. In relation to the extra shareholders' meeting, Karl Olof Borg and Else- Maj Rosenlof have left their board appointments at Active Biotech AB. After the meeting, the board has the following composition: Hugo Thelin, Chairman of the Board, Sven Andreasson, Mats Arnhog, Maria Borelius, Svend Holst-Nielsen, Mats Pettersson, Peter Sjostrand, Anders Williamsson and Hakan Astrom. The employee's representatives of the Board are Anders Hagberg and Hans Wannman. Lund 19 October 2000 Active Biotech AB (publ) Sven Andreasson, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Active Biotech AB is a Swedish biotechnology company focused on the research and development of pharmaceuticals and vaccines, the core competence being knowledge of the human immune system. Active Biotech has a high quality project portfolio and financial strength. Important products and projects include Dukoral, SBLCholera Vaccine, a vaccine against traveller's diarrhoea (ETEC ETEC enterotoxigenic Escherichia coli. ETEC Enterotoxic Escherichia coli, see there ), drugs against multiple sclerosis (SAIK SAIK Sandvikens Aik ) and cancer (TTS (1) See text-to-speech. (2) (Transaction Tracking System) Software that monitors a transaction until completion. In the event of a hardware or software failure, it ensures that the database is brought back to its former state before the attempt to ). The turnover of Active Biotech was SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 267 million in 1999. ------------------------------------------------------------ http://www.bit.se/bitonline/2000/10/19/20001019BIT01160/bit0001.doc http://www.bit.se/bitonline/2000/10/19/20001019BIT01160/bit0002.pdf |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion